A Study of GC101 TIL in Advanced Melanoma
NCT06703398
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
98
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Interventions
BIOLOGICAL:
GC101 TIL
DRUG:
dacarbazine, temozolomide, paclitaxel ,platinum or cisplatin
Sponsor
Shanghai Juncell Therapeutics